AXSM News and Press, Axsome Therapeutics Inc.

2024-07-04 10:01:38 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the critical components of the investing world is the proliferation and understanding of analyst predictions. That’s because most retail investors prefer to research consumer info...

2024-07-03 13:34:14 ET Mizhuo picks Axsome Therapeutics ( AXSM ), Wave Life Sciences ( WVE ), Arcutis Biotherapeutics ( ARQT ), LivaNova ( LIVN ) and Humana ( HUM ) as July’s top picks.... Read the full article on Seeking Alpha For further details see:...

2024-06-27 09:42:00 ET There are things that can affect and sink the stock prices of companies in most industries. One of them is a short-seller report. Axsome Therapeutics (NASDAQ: AXSM) , a mid-cap biotech, was recently the target of one, and it already wasn't having a great year ...

2024-06-22 08:27:42 ET More on Eli Lilly, Philips, etc. Eli Lilly: The Party Is Probably Nearing The End Eli Lilly And Alzheimer's Disease: The Paucity Of Progress Eli Lilly: The Road To Approval Of Donanemab Is Open Lilly weight loss drug tirzepatide meets p...

2024-06-13 11:02:01 ET More on Evergy, Coca-Cola, etc. Atlassian: Time To Initiate A Position, As Management Continues To Exceed Expectations Coca-Cola: 30%+ Upside If Dollar Gains Revert In 2024/2025 The Coca-Cola Company (KO) dbAccess Global Consumer Conference (Tr...

2024-06-11 16:30:03 ET Guggenheim analyst issues BUY recommendation for AXSM on June 11, 2024 03:28PM ET. The previous analyst recommendation was Buy. AXSM was trading at $71.07 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...

2024-06-05 08:12:48 ET More on Axsome Therapeutics Why Axsome Therapeutics Is A Promising Stock Pick In CNS Treatments Axsome Therapeutics GAAP EPS of -$1.44 misses by $0.21, revenue of $75M beats by $2.15M Axsome Therapeutics Q1 2024 Earnings Preview Seeking...

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today announced that it has entered into a settlement agreement with Un...

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, announced today it is joining the migraine advocacy community to raise awarenes...

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, announced today it is supporting Alzheimer’s & Brain Awareness Month...